Trial Profile
Targeting esophageal cancer with HDL nanoparticles: an imaging study
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 10 Jul 2018
Price :
$35
*
At a glance
- Drugs CER 001 (Primary)
- Indications Oesophageal cancer
- Focus Pharmacokinetics
- Acronyms TARGET
- 10 Jul 2018 New trial record